Literature DB >> 3259723

Inhibitor of interleukin 1 in normal human urine. Different effects on mouse thymocytes and on a murine T-cell line.

M Svenson1, K Bendtzen.   

Abstract

We investigated whether urine from normal individuals contains inhibitors of interleukin 1 (IL-1). Diafiltered urine from normal afebrile donors suppressed IL-1-induced interleukin 2 (IL-2) activity of mouse thymocyte supernatants. These supernatants, however, strongly suppressed IL-2-induced [3H]thymidine incorporation into the IL-2-sensitive cell line CTLL-2, whereas the urine preparations did not. This phenomenon was caused by an increased amount of thymidine secreted by the urine-treated thymocytes. Therefore, in order to prevent interference, experiments were carried out with excess [3H]thymidine. Under these circumstances, suppression of IL-1- and to a lesser extent IL-2-induced DNA synthesis was still observed, whereas the synergistic effect of IL-1 on IL-2-induced DNA synthesis was only marginally reduced. We conclude that suppression of IL-1-induced IL-2 production by mouse thymocytes is a major effect of the IL-1-inhibitory factor(s) in normal urine. When the murine EL4 cell line was used, the diafiltered urine failed to inhibit IL-1-induced IL-2 production. The detection of an IL-1 inhibitor in urine is therefore dependent on the target cells as well as the effects of IL-1 on these cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259723     DOI: 10.1111/j.1365-3083.1988.tb02387.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

1.  Inhibitor of interleukin-1 alpha and interleukin-1 beta-induced T-cell activation in serum of patients with active Crohn's disease.

Authors:  J Brynskov; M B Hansen; C Reimert; K Bendtzen
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

2.  Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.

Authors:  D L Eizirik; S Sandler; N Welsh; M Cetkovic-Cvrlje; A Nieman; D A Geller; D G Pipeleers; K Bendtzen; C Hellerström
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

3.  A novel urinary sialoglycoprotein as the inhibitor of interleukin-1.

Authors:  S Kabir; H Wigzell
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

4.  Quantitative cytochemical demonstration of intracellular thyroglobulin in cultured human thyrocytes. Effects of fixatives, TSH and interleukin-1 beta.

Authors:  L Kayser; B E Olsen; P E Høyer
Journal:  Histochem J       Date:  1991-05

5.  Effects of in vitro hyperthermia on the proliferative response of blood mononuclear cell subsets, and detection of interleukins 1 and 6, tumour necrosis factor-alpha and interferon-gamma.

Authors:  M Kappel; M Diamant; M B Hansen; M Klokker; B K Pedersen
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

6.  Role of infiltrating T cells for impaired glucose metabolism in pancreatic islets isolated from non-obese diabetic mice.

Authors:  E Strandell; S Sandler; C Boitard; D L Eizirik
Journal:  Diabetologia       Date:  1992-10       Impact factor: 10.122

7.  Comparison of mRNA contents of interleukin-1 beta and nitric oxide synthase in pancreatic islets isolated from female and male nonobese diabetic mice.

Authors:  M Welsh; N Welsh; K Bendtzen; J Mares; E Strandell; C Oberg; S Sandler
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

8.  Human interleukin-1 beta induced stimulation of insulin release from rat pancreatic islets is accompanied by an increase in mitochondrial oxidative events.

Authors:  D L Eizirik; S Sandler
Journal:  Diabetologia       Date:  1989-11       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.